Table 4 The difference in the number of cases in the two categories in relation to the cut-off of IMP3 overall positivity. P-values are based on chi-squared test
From: A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors
cut-off = 5% | cut-off = 10% | cut-off = 50% | |||||||
|---|---|---|---|---|---|---|---|---|---|
N positive | N negative | p-value | N positive | N negative | p-value | N positive | N negative | p-value | |
HGSC x LGSC | < 0.001 | < 0.001 | < 0.001 | ||||||
HGSC | 76 (67%) | 38 (33%) | 71 (62%) | 43 (38%) | 48 (42%) | 66 (58%) | |||
LGSC | 23 (23%) | 77 (77%) | 12 (12%) | 88 (88%) | 4 (4%) | 96 (96%) | |||
HGSC x CCC | 0.965 | 0.819 | 0.979 | ||||||
HGSC | 76 (67%) | 38 (33%) | 71 (62%) | 43 (38%) | 48 (42%) | 66 (58%) | |||
CCC | 83 (67%) | 41 (33%) | 79 (64%) | 45 (36%) | 52 (42%) | 72 (58%) | |||
HGSC x EC | < 0.001 | 0.001 | 0.119 | ||||||
HGSC | 76 (67%) | 38 (33%) | 71 (62%) | 43 (38%) | 48 (42%) | 66 (58%) | |||
EC | 21 (39%) | 33 (61%) | 19 (35%) | 35 (65%) | 16 (30%) | 38 (70%) | |||
EC x CCC | < 0.001 | < 0.001 | 0.120 | ||||||
EC | 21 (39%) | 33 (61%) | 19 (35%) | 35 (65%) | 16 (30%) | 38 (70%) | |||
CCC | 83 (67%) | 41 (33%) | 79 (64%) | 45 (36%) | 52 (42%) | 72 (58%) | |||
MC x HGSC | 0.079 | 0.064 | 0.044 | ||||||
MC | 28 (82%) | 6 (18%) | 27 (79%) | 7 (21%) | 21 (62%) | 13 (38%) | |||
HGSC | 76 (67%) | 38 (33%) | 71 (62%) | 43 (38%) | 48 (42%) | 66 (58%) | |||
MC x EC | < 0.001 | < 0.001 | 0.003 | ||||||
MC | 28 (82%) | 6 (18%) | 27 (79%) | 7 (21%) | 21 (62%) | 13 (38%) | |||
EC | 21 (39%) | 33 (61%) | 19 (35%) | 35 (65%) | 16 (30%) | 38 (70%) | |||
MC x CCC | 0.082 | 0.084 | 0.040 | ||||||
MC | 28 (82%) | 6 (18%) | 27 (79%) | 7 (21%) | 21 (62%) | 13 (38%) | |||
CCC | 83 (67%) | 41 (33%) | 79 (64%) | 45 (36%) | 52 (42%) | 72 (58%) | |||